These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 20362762

  • 1. Prosthodontic treatment of a patient with bisphosphonate-induced osteonecrosis of the jaw using a removable dental prosthesis with a heat-polymerized resilient liner: a clinical report.
    Göllner M, Holst S, Fenner M, Schmitt J.
    J Prosthet Dent; 2010 Apr; 103(4):196-201. PubMed ID: 20362762
    [Abstract] [Full Text] [Related]

  • 2. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?
    Mawardi H, Treister N, Richardson P, Anderson K, Munshi N, Faiella RA, Woo SB.
    J Oral Maxillofac Surg; 2009 Mar; 67(3):593-601. PubMed ID: 19231786
    [Abstract] [Full Text] [Related]

  • 3. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
    Dimitrakopoulos I, Magopoulos C, Karakasis D.
    Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
    [Abstract] [Full Text] [Related]

  • 4. Prosthodontic treatment during active osteonecrosis related to radiation and bisphosphonate therapy: a clinical report.
    Marunick M, Gordon S.
    J Prosthet Dent; 2006 Jul; 96(1):7-12. PubMed ID: 16872925
    [Abstract] [Full Text] [Related]

  • 5. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
    Grant BT, Amenedo C, Freeman K, Kraut RA.
    J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA, Schubert MM, Peterson DE, Seneda LM.
    Cancer; 2005 Jul 01; 104(1):83-93. PubMed ID: 15929121
    [Abstract] [Full Text] [Related]

  • 7. Osteonecrosis associated with short-term oral administration of bisphosphonate.
    Takagi Y, Sumi Y, Harada A.
    J Prosthet Dent; 2009 May 01; 101(5):289-92. PubMed ID: 19410063
    [Abstract] [Full Text] [Related]

  • 8. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P.
    Clin Ther; 2007 Aug 01; 29(8):1548-58. PubMed ID: 17919538
    [Abstract] [Full Text] [Related]

  • 9. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE, Blake FA.
    Anticancer Res; 2007 Aug 01; 27(4A):1841-5. PubMed ID: 17649782
    [Abstract] [Full Text] [Related]

  • 10. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
    Koka S, Clarke BL, Amin S, Gertz M, Ruggiero SL.
    Int J Prosthodont; 2007 Aug 01; 20(2):115-22. PubMed ID: 17455429
    [Abstract] [Full Text] [Related]

  • 11. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K, Kuijpers SC, de Jong E, van Merkesteyn JP.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb 01; 107(2):e1-7. PubMed ID: 19071040
    [Abstract] [Full Text] [Related]

  • 12. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
    Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P.
    J Oral Pathol Med; 2005 Nov 01; 34(10):613-7. PubMed ID: 16202082
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE, Sawatari Y, Fortin M, Broumand V.
    J Oral Maxillofac Surg; 2005 Nov 01; 63(11):1567-75. PubMed ID: 16243172
    [Abstract] [Full Text] [Related]

  • 14. Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm.
    Malden N, Beltes C, Lopes V.
    Br Dent J; 2009 Jan 24; 206(2):93-8. PubMed ID: 19165270
    [Abstract] [Full Text] [Related]

  • 15. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
    Melo MD, Obeid G.
    J Can Dent Assoc; 2005 Feb 24; 71(2):111-3. PubMed ID: 15691429
    [Abstract] [Full Text] [Related]

  • 16. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
    Mavrokokki T, Cheng A, Stein B, Goss A.
    J Oral Maxillofac Surg; 2007 Mar 24; 65(3):415-23. PubMed ID: 17307586
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
    Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.
    Eur Urol; 2008 Nov 24; 54(5):1066-72. PubMed ID: 18602738
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review.
    Tsai WS, Haghighi K, Placa SJ.
    Gen Dent; 2006 Nov 24; 54(3):215-9; quiz 220-2. PubMed ID: 16776417
    [Abstract] [Full Text] [Related]

  • 19. What is your diagnosis? Osteonecrosis of the jaw; unknown cause(s).
    Rhodus NL.
    Northwest Dent; 2009 Nov 24; 88(2):33, 35-7. PubMed ID: 19476043
    [No Abstract] [Full Text] [Related]

  • 20. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE, Umland EM.
    Pharmacotherapy; 2008 May 24; 28(5):667-77. PubMed ID: 18447663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.